- Home
- ELVR vs VALN Comparison
ELVR vs VALN Comparison
Compare ELVR & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVR | VALN |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | Australia | France |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 903.2M | 875.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELVR | VALN |
|---|---|---|
| Price | $54.44 | $10.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $15.75 |
| AVG Volume (30 Days) | ★ 56.5K | 18.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $151.84 | $1.62 |
| Revenue Next Year | $44.62 | $5.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.55 | $5.43 |
| 52 Week High | $69.99 | $12.25 |
Technical Indicators
Market Signals| Indicator | ELVR | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 56.27 |
| Support Level | $50.66 | $8.37 |
| Resistance Level | $68.75 | $12.22 |
| Average True Range (ATR) | 2.92 | 0.44 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 28.51 | 47.79 |
Price Performance
Historical ComparisonAbout ELVR Sayona Mining Limited American Depository Shares
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is the identification, acquisition, and evaluation of mineral exploration assets, focusing on lithium. The projects of the company include the Moblan Lithium Project, the Carolina Lithium Project, the Ewoyaa Lithium Project, North American Lithium, and other projects. The company also holds an interest in a tenement portfolio in the Pilbara region, prospective for gold and lithium.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.